Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions (BLFS)
NASDAQ:BLFS
Total Valuation
BioLife Solutions has a market cap or net worth of $991.62M. The enterprise value is $1.01B.
Market Cap$991.62M
Enterprise Value$1.01B
Share Statistics
BioLife Solutions has 47,835,213 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,835,213
Owned by Insiders19.86%
Owned by Institutions0.45%
Financial Efficiency
BioLife Solutions’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is -1.87%.
Return on Equity (ROE)-0.06
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-1.87%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee517.32K
Profits Per Employee-126.94K
Employee Count159
Asset Turnover0.21
Inventory Turnover0.84
Valuation Ratios
The current PE Ratio of BioLife Solutions is ―. BioLife Solutions’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value3.43
Price to FCF0.00
Price to Operating Cash Flow67.32
PEG Ratio―
Income Statement
In the last 12 months, BioLife Solutions had revenue of 82.25M and earned -20.18M in profits. Earnings per share was -0.44.
Revenue82.25M
Gross Profit57.75M
Operating Income-7.13M
Pretax Income-11.43M
Net Income-20.18M
EBITDA1.53M
Earnings Per Share (EPS)-0.44
Cash Flow
In the last 12 months, operating cash flow was 14.63M and capital expenditures -3.35M, giving a free cash flow of 11.29M billion.
Operating Cash Flow14.63M
Free Cash Flow11.29M
Free Cash Flow per Share0.24
Dividends & Yields
BioLife Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.05
52-Week Price Change-9.23%
50-Day Moving Average21.88
200-Day Moving Average24.25
Relative Strength Index (RSI)41.18
Average Volume (3m)457.06K
Important Dates
BioLife Solutions upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
BioLife Solutions as a current ratio of 4.54, with Debt / Equity ratio of 7.64%
Current Ratio4.54
Quick Ratio3.66
Debt to Market Cap0.01
Net Debt to EBITDA-42.57
Interest Coverage Ratio-9.92
Taxes
In the past 12 months, BioLife Solutions has paid -38.00K in taxes.
Income Tax-38.00K
Effective Tax Rate<0.01
Enterprise Valuation
BioLife Solutions EV to EBITDA ratio is 738.05, with an EV/FCF ratio of 217.27.
EV to Sales13.75
EV to EBITDA738.05
EV to Free Cash Flow217.27
EV to Operating Cash Flow134.11
Balance Sheet
BioLife Solutions has $88.58M in cash and marketable securities with $26.95M in debt, giving a net cash position of -$61.63M billion.
Cash & Marketable Securities$88.58M
Total Debt$26.95M
Net Cash-$61.63M
Net Cash Per Share-$1.29
Tangible Book Value Per Share$2.76
Margins
Gross margin is 76.50%, with operating margin of -8.67%, and net profit margin of -24.54%.
Gross Margin76.50%
Operating Margin-8.67%
Pretax Margin-13.89%
Net Profit Margin-24.54%
EBITDA Margin1.86%
EBIT Margin-8.67%
Analyst Forecast
The average price target for BioLife Solutions is $31.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$31.43
Price Target Upside52.28% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-23.12%
EPS Growth Forecast97.46%